Ohr Pharmaceutical Inc.
Aminosteroids for the Treatment of a PTP1B Associated Disease

Last updated:

Abstract:

This application is directed to the use of aminosteroid compounds for the selective inhibition of the enzyme PTP1B in a mammal for the treatment of diabetes.

Status:
Application
Type:

Utility

Filling date:

30 Jan 2020

Issue date:

27 Aug 2020